Axcellerate Pharma establishes CMO/CRO and API manufacturing facility in New Jersey,
US. Focus will be small molecule and biologics PR&D, innovative technology platforms,
filling vial and bag operations, peptide synthesis, oligonucleotide production and related
Axcellerate Pharma LLC (“Axcellerate”) is a JV set up by TCG Lifesciences USA LLC,
an affiliate of TCG Lifesciences Limited, a leading CRO engaged in drug development
and clinical trial services; with Dilip Mehta, Founder & CEO of PANORAMA
Consulting and Engineering, Inc., a leading developer of lab scale to GMP manufacturing
facilities; and Alfagen Pharma LLC, an affiliate of AlfaGene Bioscience, Inc., an
innovative biotechnology company. The facility houses state-of-the-art
technology/equipment/ infrastructure and is supported by leading industry personnel from
each of the partner firms.
"We will initially target specialized CMC and CMO activities that are time sensitive and
high value in nature, that are desirable to be located geographically close to our clients.
Axcellerate intends to leverage the strong scientific talent pool, end-to-end capabilities
and PR&D/intermediate production facilities of TCG Lifesciences Limited in India to
support its operations. This opportunity represents another significant milestone for TCG
Lifesciences’ continued expansion,” commented Swapan Bhattacharya, Managing
Director of TCG Lifesciences “as this strategic alliance will expand TCG Lifesciences’
geographic footprint and enable us to service clients in the US with a local presence
while being supported globally”.
Read the rest here